Matthew Emmens's Net Worth

$97.1 Million

Estimate Recalculated Sep 16, 2024 12:27PM EST

Who is Matthew Emmens?

Matthew Emmens has an estimated net worth of $97.1 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, VERTEX PHARMACEUTICALS INC / MA, and INCYTE CORP.

SEC CIK

Matthew Emmens's CIK is 0001298332

Past Insider Trading and Trends

2017 was Matthew Emmens's most active year for acquiring shares with 5 total transactions. Matthew Emmens's most active month to acquire stocks was the month of January. 2011 was Matthew Emmens's most active year for disposing of shares, totalling 4 transactions. Matthew Emmens's most active month to dispose stocks was the month of January. 2021 saw Matthew Emmens paying a total of $226,249.98 for 3,628.383 shares, this is the most they've acquired in one year. In 2011 Matthew Emmens cashed out on 65,735 shares for a total of $2,656,131.85, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 21
Form 3
—
0
—
—
0
No matching records found

VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.12%
-10.85K
$41.76
-$453,096.00
200.87K
Nov 16
Form 4
—
0
—
—
0
Jun 1
Form 4
-20.93%
-56.00K
$37.78
-$2,115,742.00
211.6K
Scheduled
Feb 6
Form 4
+21.42%
47.2K
$0.01
$472.01
267.6K
Feb 2
Form 4
—
0
—
—
0
Jul 13
Form 4
-4.23%
-9.73K
$55.51
-$540,389.85
220.4K
May 25
Form 4
+25.91%
47.2K
$0.01
$472.01
229.41K
Feb 3
Form 4
—
0
—
—
0
Jul 14
Form 4
+34.96%
47.2K
$0.01
$472.01
182.21K
Feb 4
Form 4
∞
134.13K
$0.01
$1,341.29
134.13K
Feb 5
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found

INCYTE CORP (INCY) Snapshot price: $60.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
May 23
No matching records found